Myonex Acquires Hubertus Clinical Trial and Wholesale Drug Business in Berlin
October 5, 2022
Myonex entered into a definitive agreement to acquire the clinical trial and wholesale drug business of Hubertus Apotheke am Salzufer in Berlin, Germany. The transaction was completed, with the acquired operation rebranded as Myonex GmbH and positioned to strengthen Myonex’s packaging and sourcing capabilities across the European Union, including support for decentralized clinical trials.
- Buyers
- Myonex
- Targets
- Hubertus Apotheke am Salzufer (Clinical Trial and Wholesale Drug Business)
- Sellers
- Bernd Drevenstedt, Christiane Drevenstedt, Owners of Hubertus Apotheke am Salzufer
- Industry
- Healthcare Services
- Location
- Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Myonex Acquires Creapharm's Pharmaceutical Services Business
May 2, 2024
Pharmaceuticals
Myonex has completed the acquisition of Creapharm's pharmaceutical services business, integrating Creapharm's clinical packaging, commercial packaging and bioservices into its global clinical trial supply platform. The deal brings Creapharm's cold-chain and ultra-cold capabilities and expands Myonex's service offering and European footprint; Creapharm founder Eric Placet has reinvested and joined the Myonex board.
-
Myonex Acquires SaveWay Compounding Pharmacy
April 10, 2024
Healthcare Services
Myonex has completed the acquisition of SaveWay Compounding Pharmacy, a Newark, Delaware-based compounding pharmacy, to expand its direct-to-patient and home healthcare capabilities for clinical trials across the United States. The purchase enhances Myonex's clinical trial supply offerings—adding compounding, drug sourcing and dispensing capabilities to support decentralized and hybrid trials nationwide.
-
Nexelis Acquires GSK Vaccines Clinical Bioanalytical Laboratory (Marburg)
January 20, 2021
Biotechnology
Nexelis, a portfolio company of Ampersand Capital Partners, has signed an asset purchase agreement to acquire GSK's GCLP-certified clinical bioanalytical laboratory in Marburg, Germany. Approximately 80 scientists and analysts will transfer to Nexelis, which also entered a five-year strategic collaboration with GSK to continue supporting vaccine development while expanding Nexelis' assay development and high-throughput clinical testing capabilities in Europe.
-
AmerisourceBergen Acquires PharmaLex for €1.28 Billion
December 31, 2022
Healthcare Services
AmerisourceBergen Corporation signed a definitive agreement to acquire PharmaLex Holding GmbH for €1.28 billion in cash. The deal is intended to expand AmerisourceBergen’s global biopharma services platform by adding PharmaLex’s tech-enabled, regulatory-focused life sciences expertise.
-
Kymanox Acquires anteris medical GmbH and anteris helvetia AG
February 2, 2023
Professional Services
Kymanox Corporation has acquired anteris medical GmbH (Germany) and anteris helvetia AG (Switzerland) to expand its European footprint and broaden its life-science professional services capabilities. The deal brings additional regulatory, quality, and combination-product expertise to Kymanox; terms were not disclosed.
-
PharmaLex Group Merges with NeoHealthHub Limited
October 13, 2022
Healthcare Services
PharmaLex Group has merged with UK-based NeoHealthHub Limited to strengthen PharmaLex’s market access and data capabilities in the UK and build a pan‑European market access practice. NeoHealthHub, headquartered in Lutterworth, Leicestershire, employs around 50 people and will expand PharmaLex’s local market access, data and capability development offerings across major European markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.